Dianthus Therapeutics, Inc. (DNTH)

Dianthus Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	771	154	24	260	379	591
Market Cap Growth	1726.92%	544.27%	-90.81%	-31.24%	-35.93%	212.80%
Enterprise Value	394	-19	-51	82	228	444
PE Ratio	6.86	-3.54	-0.84	-3.66	-5.05	-7.70
PS Ratio	341.91	54.53	3.73	-	-	-
PB Ratio	2.07	0.91	-0.54	1.51	2.63	4.19
P/FCF Ratio	-50.00	-4.17	-0.82	-4.28	-5.88	-9.82
P/OCF Ratio	-54.34	-4.18	-0.82	-4.37	-5.92	-10.35
EV/Sales Ratio	174.93	-6.73	-7.91	-	-	-
EV/EBITDA Ratio	-11.69	0.44	1.79	-1.18	-3.13	-5.92
EV/EBIT Ratio	-11.90	0.44	1.78	-1.15	-3.04	-5.78
EV/FCF Ratio	-28.62	0.51	1.74	-1.34	-3.54	-7.37
Debt / Equity Ratio	0.00	0.00	-0.02	-	-	-
Debt / EBITDA Ratio	-0.01	-0.01	-0.03	-	-	-
Debt / FCF Ratio	-0.03	-0.02	-0.03	-	-	-
Quick Ratio	42.18	18.09	9.86	16.45	13.18	10.45
Current Ratio	42.52	18.43	9.97	16.63	13.26	10.62
Asset Turnover	0.01	0.02	0.04	0	0	0
Return on Equity (ROE)	-21.30%	-34.90%	-31.10%	-41.00%	-49.80%	-49.80%
Return on Assets (ROA)	-20.30%	-32.60%	-18.50%	-37.40%	-44.60%	-45.00%
Return on Capital (ROIC)	-14.45%	-28.43%	68.16%	-43.26%	-54.69%	-58.76%
Earnings Yield	-5.49%	-28.26%	-119.05%	-27.32%	-19.79%	-12.99%
FCF Yield	-2.28%	-23.99%	-122.11%	-23.35%	-17.01%	-10.18%
Buyback Yield / Dilution	-2834.17%	-489.48%	74.54%	-25.11%	-18.66%	-101.28%
Total Shareholder Return	-2834.17%	-489.48%	74.54%	-25.11%	-18.66%	-101.28%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).